Compare PLX & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLX | FCCO |
|---|---|---|
| Founded | 1993 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.9M | 222.9M |
| IPO Year | 1998 | 1998 |
| Metric | PLX | FCCO |
|---|---|---|
| Price | $1.71 | $29.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $12.00 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 570.7K | 20.1K |
| Earning Date | 11-13-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.21% |
| EPS Growth | N/A | ★ 42.01 |
| EPS | 0.07 | ★ 2.40 |
| Revenue | $61,840,000.00 | ★ $74,180,000.00 |
| Revenue This Year | $14.53 | $22.64 |
| Revenue Next Year | $75.77 | $27.09 |
| P/E Ratio | $24.25 | ★ $12.09 |
| Revenue Growth | ★ 35.41 | 18.23 |
| 52 Week Low | $1.32 | $19.46 |
| 52 Week High | $3.10 | $29.55 |
| Indicator | PLX | FCCO |
|---|---|---|
| Relative Strength Index (RSI) | 35.14 | 66.28 |
| Support Level | $1.71 | $26.96 |
| Resistance Level | $1.86 | $29.40 |
| Average True Range (ATR) | 0.12 | 0.62 |
| MACD | -0.01 | 0.17 |
| Stochastic Oscillator | 16.67 | 97.19 |
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.